Showing session: reset
Novel Rational Checkpoint Inhibitors
- Sort by:
- Browse by:
- Free
- slides video
- audio + slides
- All slides included
Introduction
Silvia C Formenti
Weill Cornell Medical College, New York, NY, United States
- Free
- slides video
- audio + slides
- All slides included
Neoadjuvant immuno-radiotherapy (NIRT) in head and neck cancer: Phase I/Ib study of combined PD-1/SBRT prior to surgical resection
Rom Leidner
EACRI - Providence Cancer Center, Portland, OR, United States
- Free
- slides video
- audio + slides
- All slides included
Discussant
Christine H Chung
Moffitt Cancer Center, Tampa, FL, United States
- Free
- slides video
- audio + slides
- All slides included
Phase (Ph) I/II study of MBG453± spartalizumab (PDR001) in patients (pts) with advanced malignancies
Giuseppe Curigliano
Istituto Europeo di Oncologia IRCCS, Milan, Italy
- Free
- slides video
- audio + slides
- All slides included
Discussant
David S Hong
UT MD Anderson Cancer Ctr., Houston, TX, United States
- Free
- slides video
- audio + slides
- All slides included
Gilteritinib significantly prolongs overall survival in patients with FLT3-mutated (FLT3mut+) relapsed/refractory (R/R) acute myeloid leukemia (AML): Results from the Phase III ADMIRAL trial
Alexander E Perl
Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, United States
- Free
- slides video
- audio + slides
- All slides included
Discussant
Tapan M. Kadia
UT MD Anderson Cancer Ctr., Houston, TX, United States
- Free
- podium video
- audio + slides
- Some slides withheld
Phase I dose-escalation study of endoscopic intratumoral injection of OBP-301 (telomelysin) with radiotherapy in esophageal cancer patients unfit for standard treatments
Toshiyoshi Fujiwara
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
- Free
- podium video
- slides video
- audio + slides
- All slides included
Discussant
Geoffrey Y Ku
Memorial Sloan Kettering Cancer Center, New York, NY, United States